27 reports

  • MARKET LANDSCAPE

More than one million people across the globe have TB-HIV coinfection.

  • Pathology
  • Tuberculosis
  • World
  • Forecast
  • Sandoz Inc.
  • GLOBAL POPULATION AT RISK FOR SERIOUS BACTERIAL INFECTIONS, SECONDARY TO CHRONIC DISEASES BY SELECTED GEOGRAPHICAL REGION
  • DESCRIPTION OF INFECTIONS

This report takes a look at both prevention procedures such as sterilization and surface area disinfection and testing such as molecular tests and immunoassays. Infection control in healthcare facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities...

  • Tuberculosis
  • Cepheid
  • Getinge Group
  • Roche Group
  • STERIS Corporation

The structural biology of HIV-##: mechanistic and therapeutic insights.

  • Tuberculosis
  • World
  • Market Size
  • Actelion Ltd
  • Pfizer Inc.

The company expanded its offerings for the diagnosis and management of HIV infection with the introduction of Alere Determine HIV-##/ ## Ag/ Ab Combo in 2013, the first FDA-approved rapid, point-of-care test that detects both HIV-##/ ## antibodies

  • Tuberculosis
  • World
  • Market Size
  • Alere Inc.
  • Roche Group

We are also advancing our assay development across a range of other infectious diseases, with tests under early stage design in HIV and Sepsis.

  • Tuberculosis
  • India
  • World
  • Epistem Holdings Plc
  • GlobalData's company
  • Official Title
  • Clinical Trial profile. 549 Trial Title

Mycobacterium Infections Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Mycobacterium Infections Global Clinical Trials Review, H1, 2018" provides an overview of Mycobacterium Infections clinical trials scenario.This report provides top line data relating to...

  • Clinical Trial
  • Infectious Disease
  • Pharmaceutical
  • Tuberculosis
  • World
  • Clinical Trial profile. 325 Trial Title
  • Clinical Trial profile. 442 Trial Title

Mycobacterium tuberculosis Infections Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Mycobacterium tuberculosis Infections Global Clinical Trials Review, H1, 2018" provides an overview of Mycobacterium tuberculosis Infections clinical trials scenario.This report...

  • Anti-Infective
  • Clinical Trial
  • Infectious Disease
  • Tuberculosis
  • World

In fact, the number of worldwide deaths caused by tuberculosis has surpassed HIV/ AIDS, and there is greater sense of urgency than ever before to find effective drug cocktails to outsmart MTB.

  • Tuberculosis
  • United States
  • World
  • Product Initiative
  • Lycera Corp.
  • TUBERCULOSIS - PIPELINE BY RECCE LTD, H2 2017
  • TUBERCULOSIS - PIPELINE BY RODOS BIOTARGET GMBH, H2 2017

Tuberculosis - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis - Pipeline Review, H2 2017, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape. Tuberculosis, commonly known as TB,...

  • Pathology
  • Tuberculosis
  • Vaccine
  • World
  • TB Drug Development, Inc.

In fact, the number of worldwide deaths caused by tuberculosis has surpassed HIV/ AIDS, and there is greater sense of urgency than ever before to find effective drug cocktails to outsmart MTB.

  • Tuberculosis
  • United States
  • World
  • Product Initiative
  • Lycera Corp.
  • NOV 04, 2014: MBIO DIAGNOSTICS AWARDED CONTRACT FOR DIAGNOSTIC DEVELOPMENT WITH THE U.S. ARMY

Specifically, malaria, HIV/ AIDS, enteric pathogens, influenza, hemorrhagic fever viruses, and arthropod-borne diseases are among the most important of the militarily-relevant infectious agents.

  • Diagnostics
  • Tuberculosis
  • United States
  • Litigation And Patent
  • MBio Diagnostics, Inc.
  • Immunitor, Inc. - Dormant Developmental Projects,2015
  • Immunitor, Inc. - Drug Profiles

Immunitor, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Immunitor, Inc. - Product Pipeline Review - 2015’, provides an overview of the Immunitor, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental...

  • Pathology
  • Tuberculosis
  • World
  • Company Operations
  • Immunitor, Inc.

" The new CFAR builds on Einstein and Montefiore' s longstanding achievements in HIV and AIDS research and our shared commitment to social justice, " says Dr.

  • Cancer
  • Pharmaceutical
  • Therapy
  • Tuberculosis
  • United States
  • Official Title
  • Official Title

Tuberculosis Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Tuberculosis Global Clinical Trials Review, H1, 2016" provides an overview of Tuberculosis clinical trials scenario. This report provides top line data relating to the clinical trials on Tuberculosis. Report includes an overview...

  • Clinical Trial
  • Infectious Disease
  • Pharmaceutical
  • Tuberculosis
  • World
  • Clinical Trial profile. 132 Trial Title
  • Clinical Trial profile. 50 Trial Title

The prominent features of this report are - ##.

  • Anti-Infective
  • Therapy
  • Tuberculosis
  • World
  • Product Initiative
  • ISR-50 - DRUG PROFILE
  • TUBERCULOSIS - PIPELINE BY SANOFI, H1 2018

Tuberculosis - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis - Pipeline Review, H1 2018, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape. Tuberculosis, commonly known as TB,...

  • Pathology
  • Tuberculosis
  • Vaccine
  • United States
  • TB Drug Development, Inc.
  • Clinical Trial profile. 76 Trial Title
  • Clinical Trial profile. 500 Trial Title

Mycobacterium Tuberculosis Infections Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Mycobacterium Tuberculosis Infections Global Clinical Trials Review, H2, 2015" provides an overview of Mycobacterium Tuberculosis Infections clinical trials scenario. This report provides top line...

  • Clinical Trial
  • Infectious Disease
  • Pharmaceutical
  • Tuberculosis
  • World

Wave ## provides EOSCAPE-HIV, an in vitro nucleic acid assay, which enables the detection and quantitation of human immunodeficiency virus type ## (HIV-##) RNA.

  • Hepatitis
  • HIV AIDS
  • Infectious Disease
  • Pathology
  • Tuberculosis
  • NOV 04, 2014: MBIO DIAGNOSTICS AWARDED CONTRACT FOR DIAGNOSTIC DEVELOPMENT WITH THE U.S. ARMY

Specifically, malaria, HIV/ AIDS, enteric pathogens, influenza, hemorrhagic fever viruses, and arthropod-borne diseases are among the most important of the militarily-relevant infectious agents.

  • Diagnostics
  • Tuberculosis
  • United States
  • Litigation And Patent
  • MBio Diagnostics, Inc.
  • TUBERCULOSIS - PIPELINE BY RODOS BIOTARGET GMBH,
  • TUBERCULOSIS - PIPELINE BY RECCE PTY LTD,

Antibacterial Therapies Drug Development Pipeline Review, 2017 Summary The antibacterial drug market covers the drugs used in the prophylaxis and treatment of bacterial infections. With a growing global concern over antimicrobial resistance and its progressive growth, there is a pronounced need for innovation within...

  • Biotech
  • Tuberculosis
  • United States
  • Company
  • Product Initiative

December 2014, Cepheid and FIND were awarded the CE Mark for the Xpert HIV-## Viral Load, a quantitative test for measurement of the HIV-## viral load in plasma.

  • Bioinformatic
  • In Vitro Diagnostics
  • Molecular Diagnostic
  • Tuberculosis
  • Illumina, Inc.

THE DRUG CANDIDATE BY INHIBITING THE DR## ACTIVITY AIDS IN THE TREATMENT OF UNDERLYING CAUSE.

  • Breast Cancer
  • Monoclonal Antibody
  • Therapy
  • Tuberculosis
  • Daiichi Sankyo Company

HIV/ AIDS, TB AND MALARIA REMAIN THE REGION' S BIGGEST KILLERS.

  • Healthcare
  • Hospital
  • Tuberculosis
  • South Africa
  • Netcare Limited
  • Globeimmune, Inc. - Pipeline by Indication, 2015

Globeimmune, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Globeimmune, Inc. - Product Pipeline Review - 2015’, provides an overview of the Globeimmune, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental...

  • Therapy
  • Tuberculosis
  • United States
  • Company Operations
  • GlobeImmune, Inc.

It interacts with the HIV envelope protein gp##, but not with the HIV cellular receptors.

  • Infectious Disease
  • Therapy
  • Tuberculosis
  • United States
  • Sanofi S.A.
  • SMALL MOLECULES FOR TUBERCULOSIS
  • NITD-349

The partnership is a milestone toward the development of faster TB drug regimens that treat all forms of TB, are easier for patients to complete, and can be used safely in patients with HIV/ AIDS.

  • Cancer
  • Targeted Therapy
  • Therapy
  • Tuberculosis
  • Novartis AG

The drug candidate is in Phase II stage of development for the treatment of ovarian or peritoneal cancer, neurofibromatoses type I and plexiform neurofibroma in Phase I/ II stage of development for the treatment of AIDS related Kaposi' s sarcoma and gliomas.

  • Blood Disease
  • Therapy
  • Tuberculosis
  • United States
  • AstraZeneca PLC